We use cookies to better understand how you use our site and to improve your experience by personalizing content. Please review our updated Privacy Policy and Terms of Use. If you accept the use of cookies, please click the "I accept" button.I acceptI declineX
Skip navigational links

Life Sciences Newsletter, September 2008


Volume 2, Issue 2
Editor: Seth David Levy, Esq.

  • Generics: Hot Issues as Hatch-Waxman Approaches Its 25th Year
    Karen Gibbs, Esquire

  • Supreme Court Precludes State Tort Damage Claims Against Medical Device Manufacturers
    Stuart Silverman, Esquire

  • False Claims Act Retaliation Claims not Dependent upon Proof of Actual FCA Violation, but Proof Requirements Remain Unclear
    Kerry Parker, Esquire, and Daniel Levy, Esquire

  • Merck Settles Vioxx� Litigation with State Attorneys General: An Analysis
    Arnold Friede, Esquire, Elizabeth Hack, Esquire, Robert Nicholas, Esq., Paul Radensky, Esquire, and T. Reed Stephens, Esquire
© 2018 American Health Lawyers Association. All rights reserved. 1620 Eye Street NW, 6th Floor, Washington, DC 20006-4010 P. 202-833-1100 F. 202-833-1105